VEGFA and liver cancer: Again, ANGPT2 (angiopoietin-2) as a prognostic marker plays a pivotal role in liver cancer and concomitantly with ANGPT1 (angiopoietin-1) and VEGF (vascular endothelial growth factor) promoted activity hypervascularity [17].